Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mesa

Showing results (1-10 of 472) with videos related to

Pageof 48
Sort By:
Leukemia Research|February 17, 2007
The dawn of targeted therapy for primary myelofibrosis: opportunities and challengesRuben A Mesa
Clinical Advances in Hematology & Oncology : H&O|September 27, 2018
Refining the management of polycythemia veraRuben A Mesa
Future Oncology (London, England)|August 23, 2006
Practical management of classical myeloproliferative disorder patients: a clinician's guideRuben A Mesa
Biologics : Targets & Therapy|August 27, 2009
Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disordersRuben A Mesa
Blood|April 1, 2009
How I treat symptomatic splenomegaly in patients with myelofibrosisRuben A Mesa
Clinical Advances in Hematology & Oncology : H&O|June 8, 2017
Highlights in myeloproliferative neoplasms from the 2016 American Society of Hematology meeting: CommentaryRuben A Mesa
Hematology. American Society of Hematology. Education Program|November 21, 2007
Navigating the evolving paradigms in the diagnosis and treatment of myeloproliferative disordersRuben A Mesa
International Journal of Hematology|November 15, 2002
Clinical and scientific advances in the Philadelphia-chromosome negative chronic myeloproliferative disordersRuben A Mesa
Clinical Advances in Hematology & Oncology : H&O|September 24, 2019
Highlights in myeloproliferative neoplasms from the 60th American Society of Hematology Annual Meeting: commentaryRuben A Mesa
Current Opinion in Hematology|February 28, 2008
New insights into the pathogenesis and treatment of chronic myeloproliferative disordersRuben A Mesa
Pageof 48

Showing results (1-10 of 472) with videos related to

Sort By:
Pageof 48
Leukemia Research|February 17, 2007
The dawn of targeted therapy for primary myelofibrosis: opportunities and challengesRuben A Mesa
Clinical Advances in Hematology & Oncology : H&O|September 27, 2018
Refining the management of polycythemia veraRuben A Mesa
Future Oncology (London, England)|August 23, 2006
Practical management of classical myeloproliferative disorder patients: a clinician's guideRuben A Mesa
Biologics : Targets & Therapy|August 27, 2009
Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disordersRuben A Mesa
Blood|April 1, 2009
How I treat symptomatic splenomegaly in patients with myelofibrosisRuben A Mesa
Clinical Advances in Hematology & Oncology : H&O|June 8, 2017
Highlights in myeloproliferative neoplasms from the 2016 American Society of Hematology meeting: CommentaryRuben A Mesa
Hematology. American Society of Hematology. Education Program|November 21, 2007
Navigating the evolving paradigms in the diagnosis and treatment of myeloproliferative disordersRuben A Mesa
International Journal of Hematology|November 15, 2002
Clinical and scientific advances in the Philadelphia-chromosome negative chronic myeloproliferative disordersRuben A Mesa
Clinical Advances in Hematology & Oncology : H&O|September 24, 2019
Highlights in myeloproliferative neoplasms from the 60th American Society of Hematology Annual Meeting: commentaryRuben A Mesa
Current Opinion in Hematology|February 28, 2008
New insights into the pathogenesis and treatment of chronic myeloproliferative disordersRuben A Mesa
Pageof 48